Lombardi, G
Musco, S
Wyndaele, J J
Del Popolo, G
Article History
Received: 3 March 2015
Revised: 12 May 2015
Accepted: 1 June 2015
First Online: 21 July 2015
Change Date: 4 December 2015
Change Type: Correction
Change Details: This article has been corrected since advance online publication and a corrigendum is also printed in this issue.
Competing interests
: Dr Giulio Del Popolo is a consultant at Hollister, Ipsen, Allergan, Wellspect and Apogepha; speaker at Astellas, Allergan and Sigma Tau; and involved in trial participation at Pfizer, Allergan, Ipsen, Recordati and Astellas. The remaining authors declare no conflict of interest.
Free to read: This content has been made available to all.